Extended Spectrum Beta-Lactamase (ESBL)

Authors

  • Verna Biutifasari Fakultas Kedokteran. Universitas Hang Tuah

DOI:

https://doi.org/10.30649/obj.v1i1.3

Keywords:

antibiotic(s), resistance, ESBL

Abstract

Antibiotics have been widely used today. Use of antibiotics is also often used in mass
and not in accordance with the indication, among others, in a particular case of fish
poisoning on the beach, often the treatment is given antibiotics without clearly
indication. Use of antibiotics are excessive and not in accordance with the clinical, can
cause resistance to these antibiotics
One of the antibiotics used is a beta-lactam antibiotic, that works inhibits cell walls.
The inappropriate use of beta-lactam antibiotics can lead to resistance to these
antibiotics. Resistance to beta-lactam can occur at various levels. One of the resistances
can occur is resistance to Extended Spectrum Broad Lactamase (ESBL)
Extended spectrum beta-lactamase is an enzyme that has the ability to hydrolyze
penicillin-type antibiotics, first-generation cephalosporins, two, and three as well as
monobactam groups and cause resistance throughout the antibiotic.
ESBL is produced by many Enterobactericeae (especially Escherichia coli) and
Klebsiella pneumoniae. Enterobacteriaceae has 3 resistance patterns caused by broadspectrum beta-lactamase, beta-lactamase-resistant inhibitors (TEM derivatives),
excessive cephalosporinase. ESBL can be difficult to detect because ESBL has
differentiatedactivity to various cephalosporins
ESBL can be detected in clinical microbiology (phenotypic) and molecular detection
(genotypic)

References

Bradford, P., 2001. Extended-spectrum β-lactamase in the 21st century:

Characterization, Epidemiology, and Detection of this Important Resistance

Threat.. Clinical Microbiology, 30(4), pp. 933-951.

Caroll KC; Glanz BD; Borek AP; Bhally HS; Henciak S; Flayhart D, 2006. Evaluation

of The BD Phoenix Automated Microbiology System for Identification and

Antimicrobial Susceptibility Testing. Journal of Microbiology, 44(10), pp.

-3509.

Deschen CT; Shymassre D; Luna A; Ranabial Pal; Takhelimban SK, 2009. Extended

spectrum β-lactamase detection in gram negatif bactery of nosocomial origin.

Journal Global Infection Disease, 1(2), pp. 87-92.

Drieue L; Brossier F; Sougakoff W; Jarlier V, 2008. Phenotypic detection of extendedspectrum β-lactamase production in Enterobabteriaceae: review and bench

guide. Clinical Microbiology Infection Journal , 14(1), pp. 90-103.

Forbes BA ; Weissfeld AS; Sahm DF, 2007. Laboratory Methods and Strategies for

Antimicrobial Susceptibility Testing . In: Bailey & Scotts's Diagnostic

Microbiology . Philladelpia: Elsevier, pp. 187-213.

http://www.rsc.org

www.wiley.com

Isenberg, H., 1998. Essential Prosedures for Clinical Microbiology. Washington: ASM

Press.

Jean B Patel; Melvin P Weinstein; George M Polipous, 2017. Screening and

Confirmatory Test for ESBL. In: M100-S22. Performance Standards for

Antimicrobial Susceptibility Testing. 27 ed. Wayne: Clinical and Laboratory

Standard Institute.

Lalitha, M., 2017. Manual on Antimicrobial Susceptibility Testing.

www.ijmm.org/document/antimicrobial.com. [Online]

[Accessed 1 Agustus 2017].

Patologi Klinik RSUD Dr Soetomo -FK UNAIR 2010. Semiloka Mikrobiologi.

Rupp ME; Fey PD, 2003. Extended Spectrum β-lactamase (ESBL)- Producing

Enterobacteriaceae Consideration for Diagnosis, Prevention and Drug

Treatmment. DIagnosis Microbiology Infection Diseases, 63(4), pp. 353-365.

Thomson KE; Cornish NE; Hong, Hemrick Kim; Herdt C; Mollan ES., 2007.

Comparison of Phoenix and Vitek 2 Extended-spectrum β-lactamase Detection

Tests for analysis of Escherichia coli and Klebsiella Isolates with WellCharacterized β-lactamases, Orlando : ASM.

Thomson KE; Molland ES., n.d. Comparison of Phoenix and Vitek 2 ESBL

Confirmatory Tests against E.coli and Klebsiella Isolates with wellcharacterized β-lactamases. As presented at the 106 th General Meeting of the

American Society for Microbiology (ASM) O.

Turng B; Votta M; Turner D, Pollit J; Callihan D; Wullf S; Wiles T , 2012. Detection

of Extended Spectrum Beta-lactamase Among Enterobacteriaceae Using

PhoenixTM Automated Microbiology System with BDXpertTM System, San

Diego: Interscience Conference on Antimicrobial Agents and Chemotherapy

(ICAC).

Published

2018-01-05

How to Cite

Biutifasari, V. (2018). Extended Spectrum Beta-Lactamase (ESBL). Oceana Biomedicina Journal, 1(1), 3. https://doi.org/10.30649/obj.v1i1.3